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Abstract
Background: In accordance with an ongoing activity for
worldwide harmonization based on traceability in laboratory
methods, the goal of this study was to validate the applica-
bility of recommended ‘‘common’’ reference intervals for
serum creatinine concentrations using a specific enzymatic
method to the Croatian population.
Methods: The reference group consisted of 240 healthy sub-
jects (120 males and 120 females), between 18 and 74 years
of age (median 57 years), who were selected in accordance
with the International Federation of Clinical Chemistry and
Laboratory Medicine (IFCC) recommendations. Creatinine in
serum was measured using the creatinine enzymatic assay
(Olympus OSR61204) that was standardized to the isotopic
dilution mass spectrometry (IDMS) method and National
Institute of Standards and Technology (NIST) Standard Ref-
erence Material (SRM) 967. In addition, creatinine was
measured using a kinetic Jaffe method (Olympus OSR6178)
standardized to NIST SRM 909b level 2 standard.
Results: Method comparison between enzymatic creatinine
(x) and the Jaffe kinetic method (y) gave the following P/B
equation for the entire group (ns240): ys1.00xq17.00;
rs0.968. Reference intervals for serum creatinine (central
95th percentiles) obtained using the enzymatic creatinine
method ranged from 54 to 107 mmol/L for males and from
50 to 93 mmol/L for females. The IFCC recommended com-
mon reference intervals for global applications are 64–104
mmol/L and 49–90 mmol/L for males and females,
respectively.
Conclusions: Comparability of obtained results confirmed
the applicability of recently recommended ‘‘common’’ ref-
erence intervals to the Croatian population for all laboratories
measuring serum creatinine concentrations using enzymatic
methods traceable to the IDMS method and NIST SRM 967.
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Introduction
Variability of the clinically relevant blood constituents
throughout an individual’s lifetime depends on various phys-
iological processes and numerous biological factors which
define characteristics of any population (1, 2). Population
based reference intervals for clinically relevant blood and
serum constituents for the Croatian population were pro-
duced under strictly controlled conditions according to the
International Federation of Clinical Chemistry and Labora-
tory Medicine (IFCC) recommendations proposed by the
Clinical and Laboratory Standards Institute (CLSI) C28 doc-
ument (3). These reference intervals were based upon a rep-
resentative reference sample group of 2246 adults and 998
children, aged 8–70 years, during the period from 1998 to
2000 (4–7). All tests were performed by the Institute of Clin-
ical Chemistry at the University Hospital Merkur, ‘‘Refer-
ence Center of Ministry of Health and Social Care for
Producing Reference Values in the Field of General Medical
Biochemistry’’, Zagreb, Croatia, using routine analytical
methods. Serum creatinine concentrations were measured
using an uncompensated kinetic Jaffe method. In order to
harmonize laboratory results, the Croatian Chamber of Med-
ical Biochemists recommended the application of obtained
reference intervals for all laboratories using the same ana-
lytical methods in January, 2005 (8). Results that are
obtained are evaluated through the laboratories participation
in the national External Quality Assessment (EQA). The
EQA has been performed continuously since 1973 by the
Committee for External Quality Assessment in Medical Bio-
chemical Laboratories under the auspices of the Croatian
Society of Medical Biochemists (9). A review of long-term
results collected from EQA surveys has shown that serum
creatinine concentration in almost 200 medical biochemical
laboratories in Croatia are measured with average CV
between 4.3% and 6.2% when using an uncompensated
kinetic Jaffe method. National results for creatinine concen-
trations in the International Measurement Evaluation Pro-
gram-17 (IMEP-17) measured with Jaffe methods in 28
medical biochemical laboratories in clinical hospitals showed
a significantly positive bias to the isotopic dilution mass
spectrometry (IDMS) certified reference material (CRM),
with differences up to 30% (10).
Due to the recent international requirement for accurate
and specific diagnostic tests and implementation of calibra-
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Table 1 Metrological characteristics for serum creatinine measurements using the uncompensated kinetic Jaffe method and enzymatic
method with two concentrations of commercially available controls.
Quantity Method Metrological quality
Olympus control serum 1 Olympus control serum 2
n x CVM eSr n x CVM eSr
S-creatinine; Jaffe kinetic 71 116.3 2.7 0.3 71 455.3 2.3 0.7
subst.c., mmol/L Enzymatic 48 107.4 2.3 0.6 79 454.1 1.5 1.1
S, serum; subst.c., substance concentration; n, number of control results; x, mean concentration observed; CVM, day-to-day imprecision
(%); eSr, relative systematic error (% with regard to the assigned value).
tion traceability to high order reference measurement pro-
cedures and reference materials (11–14), the goal of this
study was to validate the applicability of recommended
‘‘common’’ reference intervals for serum creatinine concen-
trations using a specific enzymatic method. We wished to
validate reference intervals in the Croatian population using
the enzymatic method instead of previously produced refer-
ence intervals established using an uncompensated kinetic
Jaffe creatinine method. This work was performed as a pre-
requisite for standardization of serum creatinine measure-
ments and harmonization of measured results.
Materials and methods
Reference individuals and samples
The reference population group consisted of 240 healthy adults (120
males and 120 females), aged between 18 and 74 years (median
57 years), from an urban population of Zagreb, Croatia. During
2008, all subjects were selected and declared healthy on the basis
of a questionnaire and results of standard laboratory tests including
measurement of alanine and aspartate aminotransferase, alkaline
phosphatase, g-glutamyltransferase, cholinesterase, lactate dehydro-
genase, glucose, total proteins, total bilirubin, urea, urate, C-reactive
protein and a complete blood count. Before collection of blood, each
individual completed a simple questionnaire requesting information
about age, gender, height, weight, heredity for diabetes, severe dis-
ease, prescribed drugs, food preferences and cigarette smoking.
None of reference individuals had a history of severe diseases and
none of the women were pregnant. Smokers were included while
individuals taking any prescribed drugs were excluded from the ref-
erence population group. None of the reference individuals were
vegetarian. Women had a mean weight of 71.5 kg (ss8.9 kg) and
a mean height of 1.64 m (ss0.05 m) and men had a mean weight
of 86.1 kg (ss10.6 kg) and a mean height of 1.87 m (ss0.05 m).
Results of standard laboratory tests for all subjects were within pre-
viously established reference intervals for the Croatian population
(4, 5, 7). This study was performed with permission from the Ethical
Committee of Medical School University of Zagreb, Croatia, and
written consent was obtained from all participants.
Venous blood was collected under controlled conditions into
vacutainer tubes (Becton Dickinson, Plymouth, England) containing
no additives. Serum was prepared 30 min after blood collection by
centrifugation at 1800=g, and sera were frozen at –808C until
analysis.
Measurement methods
All measurements were performed using an Olympus AU 600 ana-
lyzer (Olympus Mishima Co., Ltd., Shizuoka, Japan) using Olym-
pus reagents. Serum creatinine concentrations were measured using
the conventional kinetic uncompensated Jaffe method (Olympus
OSR6178) and by an enzymatic assay (Olympus OSR61204). The
analyzer was calibrated using the manufacturer’s calibrator (Olym-
pus Cat. No. 66300). The creatinine concentration for the serum
calibrator was traceable to the IDMS method and National Institute
of Standards and Technology (NIST) Standard Reference Material
(SRM) 967 for the enzymatic method, and to the NIST SRM 909b
level 2 for the conventional kinetic uncompensated Jaffe method.
The commercial control sera for normal (ODC0003 Olympus con-
trol level 1) and pathological (ODC0004 Olympus control level 2)
concentrations were used for evaluation of metrological character-
istics of the measurement procedures. Reference intervals were cal-
culated using MedCalc statistical software (http://www.medcalc.be).
The established reference intervals reflected our estimate of the
2.5–97.5 percentiles for a non-parametric distribution.
Regression analysis for comparison of methods was done using
the non-parametric Passing/Bablok method, and a linear regression
model was used to establish correlation coefficients.
Results
Quality control data
During the study, the same control materials were used, the
Olympus control serum level 1 and Olympus control serum
level 2, Ireland. Metrological characteristics of measurement
procedures used to produce reference values for creatinine
concentrations in serum are shown as day-to-day imprecision
and the relative systematic error. Relative systematic errors
were calculated with respect to the assigned values of control
materials. The data for long-term analytical imprecision and
inaccuracy (expressed as the relative systematic error)
obtained under controlled pre-analytical conditions are pre-
sented in Table 1. Our results showed better metrological
characteristics for the enzymatic creatinine method calibrated
to NIST SRM 967 as compared to the uncompensated Jaffe
method calibrated to NIST SRM 909b level 2. Based on
biological variability, current desired goals for laboratory
performance for creatinine measurements are 2.8% for inac-
curacy and 2.2% for imprecision (15). Considering both
imprecision and inaccuracy in making an estimate of
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Table 2 Common reference intervals for creatinine concentra-
tions in serum compared to reference intervals for adult Croatian
population produced using an enzymatic method traceable to the
IDMS method and NIST SRM 967.
Age (gender) group Percentile value, mmol/L
2.5th 97.5th
Common reference intervals
for global application (20)
Cord sera 46 86
Term neonates 0–14 d 27 81
2 m–-1 y 14 34
1 y–-3 y 15 31
3 y–-5 y 23 37
5 y–-7 y 25 42
7 y–-9 y 30 48
9 y–-11 y 28 57
11 y–-13 y 37 63
13 y–-15 y 40 72
Adult (males) 64 104
Adult (females) 49 90
Reference intervals in the
reference sample group of
Croatian population (ns240)
Adult (males) 54 107
Adult (females) 50 93
d, days; m, months; y, years; n, number of reference subjects.
Table 3 Reference intervals for creatinine concentrations in
serum for school children and adolescents (ns998) and adults
(ns2246) in Croatians compared to current data obtained in the
reference sample group of adult reference individuals from the
same population using conventional uncompensated Jaffe kinetic
method traceable to the IDMS method and NIST SRM 909b
level 2.




8 y–-13 y (males, females) 46 80
14 y–-18 y (males) 60 104
14 y–-18 y (females) 57 96
20 y–-70 y (males) 79 125
20 y–-70 y (females) 63 107
Current data on reference
intervals in the reference
sample group of Croatians
(ns240)
Adult (males) 70 126
Adult (females) 66 110
y, years; n, number of reference subjects.
analytical performance required to meet the clinical interpre-
tation goals for serum creatinine measurements, the recom-
mended desirable goal of 8.2% for total error (16) was
achieved for both methods.
Method comparison
Method comparison between the enzymatic creatinine meth-
od (x) and uncompensated Jaffe kinetic method (y) gave the
following Passing/Bablok equation for the whole group of
240 individuals: ys1.00xq17.00 and a correlation coeffi-
cient of 0.968. As expected, the creatinine uncompensated
Jaffe method gave substantially higher values compared with
the enzymatic method. These results are in accordance with
several studies that compared an enzymatic method with the
non-specific conventional Jaffe method. These results indi-
cate that Jaffe methods, based on an alkaline picrate reaction,
overestimate true serum creatinine concentrations due pri-
marily to non-specific protein interference (17–19).
Reference intervals for serum creatinine
The central 95th percentile reference interval was determined
using the reference population of 240 healthy adult persons.
The interval obtained using the enzymatic assay traceable to
IDMS and SRM 967 ranged from 54 to 107 mmol/L in
males, and from 50 to 93 mmol/L in females. These ranges
can be compared to the recommended common reference
intervals for global application of 64–104 and 49–90 mmol/L
for males and females, respectively (Table 2).
The reference intervals for the uncompensated kinetic
Jaffe method traceable to the IDMS method and SRM 909b
level 2 was found to be 70–126 mmol/L in males and
66–110 mmol/L in females. This range was almost identical
with the reference intervals produced in our previous study
(6) using a group of 2246 healthy adults: 79–125 mmol/L
and 63–107 mmol/L for males and females, respectively.
Detailed data are presented in Table 3.
Discussion
Reference intervals for healthy subjects are very important
for the clinical interpretation of laboratory test values (21,
22). The quality of reference intervals can play a large role
in result interpretation as the quality of the result itself. The
International Organization for Standardization (ISO) and
Standard 15189 requests that ‘‘biological reference intervals
shall be periodically reviewed’’ (23). The European Union
Directive on In Vitro Diagnostics Medical Devices (IVD
MD) asks manufacturers to provide detailed information on
reference intervals and to provide traceability to reference
methods and materials for analytes (13). More recently, the
NIST prepared a secondary commutable creatinine reference
material designated SRM 967 which became available to the
IVD industry (24). SRM 967 has a frozen serum matrix and
is intended for use by laboratories and in vitro diagnostics
equipment manufactures for the calibration and evaluation of
routine clinical methods (25). Several studies indicate that
introducing specific enzymatic methods for creatinine meas-
urements in the routine laboratory should guarantee trace-
ability of each individual reference result to the reference
measurement system (17, 20). Because the NIST SRM 909b
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reference material that was previously used is not commut-
able with native human serum, it is unsuitable for direct cal-
ibration of routine methods (24).
In order to establish traceability for creatinine measure-
ments and to harmonize laboratory results and their interpre-
tation for clinical use, we validated the applicability of
recommended ‘‘common’’ reference intervals for serum cre-
atinine concentrations using an enzymatic method traceable
to the IDMS method and SRM 967 to the Croatian popula-
tion. This was done instead of using reference intervals
established previously using an uncompensated kinetic Jaffe
method traceable to the IDMS method and SRM 909b level
2. Creatinine results for the reference population group of
240 healthy adult persons obtained under controlled pre-ana-
lytical conditions and with analytical quality within desirable
target values using a specific enzymatic creatinine method
showed essentially identical results compared with recently
recommended ‘‘common’’ reference intervals for global
application by the IFCC Committee on Reference Intervals
and Decision Limits (20). Due to the fact that creatinine con-
centrations with respect to age and gender in our population-
based study measured using an uncompensated kinetic Jaffe
method (4–6) are quite similar to those reported in recently
recommended ‘‘common’’ reference intervals for global
application (20), it appears that ‘‘common’’ reference inter-
vals could be adopted for all age groups. Based on validation
results, we obtained, all prerequisites for adopting established
common reference intervals for creatinine measurement were
fulfilled.
Recommended ‘‘common’’ reference intervals for global
application could be used for creatinine measurement on a
national level by all laboratories that use a standardized, spe-
cific enzymatic method traceable to the commutable high-
order reference material NIST SRM 967. In addition, they
need to demonstrate that using controlled pre-analytical con-
ditions, their analytical performance meets the recommended
performance goal of -10% total error based on biological
variability and clinical requirements (15, 26, 27). According
to guidelines from the CLSI, validation of reference intervals
can be performed using a small sample of 20 reference indi-
viduals from the laboratory’s population (28).
In case of serum creatinine, standardization is of particular
importance because of its role in the assessment of renal
function and for estimation of glomerular filtration rate (29,
30). Introducing the enzymatic creatinine method to routine
laboratory work, instead of the alkaline picrate method, is in
accordance with recent recommendations of the Laboratory
Working Group of the National Kidney Disease Education
Program. This group suggests that the estimated glomerular
filtration rate has to be reported using accurate and specific
serum creatinine measurements, based on the concept of
traceability (16).
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